Balgopal Commercial Limited submitted a regulatory disclosure to BSE Limited regarding the utilization of funds raised through preferential issue of equity shares and warrants for the quarter ended June 30, 2026.
The company confirmed that there was no deviation or variation in the use of funds raised through preferential issue of shares and warrants from the objects stated in the Explanatory Statement to the Notice of Extra-Ordinary General Meeting dated December 10, 2024.
Key Details of Fund Raising
- Mode of Fund Raising: Preferential Issue (Conversion of warrants)
- Date of Raising Funds: June 4, 2026
- Funds Received Date: June 4, 2026
- Share Allotment Date: June 6, 2026 (upon conversion of warrants)
- Amount Raised: ₹10,52,10,000 (₹10.52 crore)
Utilization Details
Funds were raised for the following objects with no deviation reported:
- To acquire/make investments in similar line of business activity
- Meeting long term funding requirements of the Company
- Working capital and general corporate purposes
- To support the future growth plan of the Company
Additional Information
- Shareholder approval date: Not Applicable (since no deviation)
- Explanation for deviation: Not Applicable
- Audit Committee comments: Not Applicable
- Auditor comments: Not Applicable
The disclosure was signed by Ankit Ladha, Company Secretary & Compliance Officer (ICSI Membership No: A74941) on August 11, 2026.